Does atorvastatin reduce ischemia-reperfusion injury in humans in-vivo?
Phase of Trial: Phase IV
Latest Information Update: 02 Jun 2011
At a glance
- Drugs Atorvastatin (Primary)
- Indications Reperfusion injury
- Focus Pharmacodynamics
- 31 Aug 2018 Biomarkers information updated
- 24 Mar 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 06 Oct 2008 Planned end date changed from 1 Jun 2007 to 1 Dec 2008 as reported by ClinicalTrials.gov.